2017;60(2):401-425. doi: 10.3233/JAD-170424. Kishi T(1), Matsunaga S(1), Oya K(1), Nomura I(1), Ikuta T(2), Iwata N(1). IOS Press IOS Press doi: 10.1001/jamanetworkopen.2018.4080.Schmidt R, Hofer E, Bouwman FH, Buerger K, Cordonnier C, Fladby T, Galimberti D, Georges J, Heneka MT, Hort J, Laczó J, Molinuevo JL, O'Brien JT, Religa D, Scheltens P, Schott JM, Sorbi S.Eur J Neurol. Abstract Introduction Alzheimer's disease (AD) is a degenerative brain disease that progresses over time, heavily burdening patients, families, and aging societies worldwide. COVID-19 is an emerging, rapidly evolving situation. 2018 Nov 2;1(7):e184080. 2019 May;36(5):435-452. doi: 10.1007/s40266-019-00648-x.Neuropsychiatr Dis Treat. It is incu … [9] Thancharoen O, Limwattananon C, Waleekhachonloet O, Rattanachotphanit T, Limwattananon P, Limpawattana P.Drugs Aging. Thus, starting from memantine, a compound currently prescribed for the treatment of moderate-to-severe Alzheimer’s disease, we created a new chemical entity, named memit, by … 2015 Jun;22(6):889-98. doi: 10.1111/ene.12707. eCollection 2017.PLoS One. Author information: (1)Department of Psychiatry, Fujita Health 2019 May;36(5):435-452. doi: 10.1007/s40266-019-00648-x.Neuropsychiatr Dis Treat. Memantine may be used as an option for managing Alzheimer’s disease for people with: moderate Alzheimer’s disease who are intolerant of or have a contraindication to AChE inhibitors Unable to load your collection due to an error Axura and Ebixa are two of the drugs approved for use in Germany to treat Alzheimer’s. IOS Press Unable to load your delegates due to an error 2015 Apr 10;10(4):e0123289. Alzheimer's dementia represents organ failure of the brain. eCollection 2020.Int J Mol Sci. 2015 Apr 10;10(4):e0123289. doi: 10.1001/jamanetworkopen.2018.4080.Schmidt R, Hofer E, Bouwman FH, Buerger K, Cordonnier C, Fladby T, Galimberti D, Georges J, Heneka MT, Hort J, Laczó J, Molinuevo JL, O'Brien JT, Religa D, Scheltens P, Schott JM, Sorbi S.Eur J Neurol. This site needs JavaScript to work properly. 2020 May 26;11:778. doi: 10.3389/fphar.2020.00778. 2018 Nov 2;1(7):e184080. Name must be less than 100 characters 2020 May 26;12(5):323-338. doi: 10.4252/wjsc.v12.i5.323.Front Pharmacol. This site needs JavaScript to work properly. Memantine will be prescribed by a specialist doctor. Memantine is believed to help prevent excess levels of the substance glutamate from damaging the brain. Unable to load your collection due to an error COVID-19 is an emerging, rapidly evolving situation. Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis J Alzheimers Dis. doi: 10.1371/journal.pone.0123289. 2020 May 26;11:778. doi: 10.3389/fphar.2020.00778. 2020 Apr 26;21(9):3059. doi: 10.3390/ijms21093059. IOS Press It is approved for people who have moderate to severe Alzheimer’s. Thancharoen O, Limwattananon C, Waleekhachonloet O, Rattanachotphanit T, Limwattananon P, Limpawattana P.Drugs Aging. eCollection 2020.Int J Mol Sci. Unable to load your delegates due to an error 2020 Apr 26;21(9):3059. doi: 10.3390/ijms21093059. Therapeutic Summary Memantine monotherapy is recommended by NICE as an option for managing1,2. doi: 10.1371/journal.pone.0123289. Epub 2015 Mar 25.Sci Rep. 2020 Sep 2;10(1):14503. doi: 10.1038/s41598-020-71587-6.Med Clin North Am. eCollection 2015.JAMA Netw Open. It denotes a clinical milestone that is the result of a pathological process, Alzheimer's disease (AD), which over 1 or more decades has wrought insidious destruction, and finally overwhelmed the brain's capacities to compensate.